BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1050 related articles for article (PubMed ID: 22075075)

  • 21. Glottic closure patterns: type I thyroplasty versus type I thyroplasty with arytenoid adduction.
    Li AJ; Johns MM; Jackson-Menaldi C; Dailey S; Heman-Ackah Y; Merati A; Rubin AD
    J Voice; 2011 May; 25(3):259-64. PubMed ID: 20335002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medialization Thyroplasty and Arytenoid Adduction for Management of Neurological Vocal Fold Immobility.
    Prasad VMN; Remacle M
    Adv Otorhinolaryngol; 2020; 85():85-97. PubMed ID: 33166967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medialization thyroplasty with a customized silicone implant: clinical experience.
    Chrobok V; Pellant A; Sram F; Fric M; Praisler J; Prymula R; Svec JG
    Folia Phoniatr Logop; 2008; 60(2):91-6. PubMed ID: 18235197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arytenoid adduction combined with nerve-muscle pedicle flap implantation or type I thyroplasty.
    Kodama N; Kumai Y; Sanuki T; Yumoto E
    Laryngoscope; 2017 Jan; 127(1):159-166. PubMed ID: 27112111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Features of Vocal Fold Adductor Paralysis and the Management of Posterior Muscle in Thyroplasty.
    Konomi U; Tokashiki R; Hiramatsu H; Motohashi R; Sakurai E; Toyomura F; Nomoto M; Kawada Y; Suzuki M
    J Voice; 2016 Mar; 30(2):234-41. PubMed ID: 26183535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The study of vocal fold vibratory patterns in patients with unilateral vocal fold paralysis before and after type I thyroplasty with or without arytenoid adduction.
    Thompson DM; Maragos NE; Edwards BW
    Laryngoscope; 1995 May; 105(5 Pt 1):481-6. PubMed ID: 7760662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arytenoid asymmetry: Is it the most predictive parameter for arytenoid adduction in unilateral vocal fold paralysis?
    Menon JR; Mathew AS; Nath S
    J Laryngol Otol; 2021 Feb; 135(2):159-167. PubMed ID: 33593469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term voice outcomes of laryngeal framework surgery for unilateral vocal fold paralysis.
    Mes SD; Hendriksma M; Heijnen BJ; Goudsmit BFJ; Jansen JC; Langeveld APM; Sjögren EV
    Eur Arch Otorhinolaryngol; 2022 Apr; 279(4):1957-1965. PubMed ID: 34787700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unilateral Vocal Fold Paralysis With Large Posterior Glottic Gap: Is Arytenoid Procedure Necessary?
    Yılmaz T; Özer F
    Ann Otol Rhinol Laryngol; 2022 Aug; 131(8):859-867. PubMed ID: 34535066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arytenoid adduction and type I thyroplasty in the treatment of aphonia.
    Slavit DH; Maragos NE
    J Voice; 1994 Mar; 8(1):84-91. PubMed ID: 8167793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagen injection as a supplement to arytenoid adduction for vocal fold paralysis.
    Kimura M; Nito T; Imagawa H; Tayama N; Chan RW
    Ann Otol Rhinol Laryngol; 2008 Jun; 117(6):430-6. PubMed ID: 18646439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adduction arytenopexy: a new procedure for paralytic dysphonia with implications for implant medialization.
    Zeitels SM; Hochman I; Hillman RE
    Ann Otol Rhinol Laryngol Suppl; 1998 Sep; 173():2-24. PubMed ID: 9750545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voice outcomes following medialization laryngoplasty with and without arytenoid adduction.
    Zimmermann TM; Orbelo DM; Pittelko RL; Youssef SJ; Lohse CM; Ekbom DC
    Laryngoscope; 2019 Aug; 129(8):1876-1881. PubMed ID: 30582612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arytenoid adduction as an adjunct to type I thyroplasty for unilateral vocal cord paralysis.
    Kraus DH; Orlikoff RF; Rizk SS; Rosenberg DB
    Head Neck; 1999 Jan; 21(1):52-9. PubMed ID: 9890351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment outcome of type 1 thyroplasty using novel titanium medialization laryngoplasty implant combined with arytenoid adduction for unilateral vocal cord paralysis: single-arm interventional study at a single institution.
    Sano D; Matsushima K; Isono Y; Ikui Y; Kinutani Y; Chiba Y; Hirose H; Oridate N
    Laryngoscope Investig Otolaryngol; 2020 Oct; 5(5):895-902. PubMed ID: 33134537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phonatory effects of type I thyroplasty implant shape and depth of medialization in unilateral vocal fold paralysis.
    Orestes MI; Neubauer J; Sofer E; Salinas J; Chhetri DK
    Laryngoscope; 2014 Dec; 124(12):2791-6. PubMed ID: 25046146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex Differences in Pitch Range and Speech Fundamental Frequency After Arytenoid Adduction and Thyroplasty.
    Konomi U; Watanabe Y; Komazawa D
    J Voice; 2016 May; 30(3):362-70. PubMed ID: 25998408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early arytenoid adduction for vagal paralysis after skull base surgery.
    Bielamowicz S; Gupta A; Sekhar LN
    Laryngoscope; 2000 Mar; 110(3 Pt 1):346-51. PubMed ID: 10718417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anterior and posterior medialization (APM) thyroplasty.
    Hong KH; Kim JH; Kim HK
    Laryngoscope; 2001 Aug; 111(8):1406-12. PubMed ID: 11568577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short- and long-term outcomes after silastic medicalization laryngoplasty: are arytenoid procedures needed?
    Benninger MS; Manzoor N; Ruda JM
    J Voice; 2015 Mar; 29(2):236-40. PubMed ID: 25510165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.